Compl-AI is a predictive tool that helps clinical trial sponsors optimize patient recruitment and engagement strategies. Nonadherence in clinical trials and high rates of dropout make efficacy and safety more difficult to determine.
2022 was a year of remarkable success for Cognivia.
Thank you to our team, partners and clients for your continued support! Here are highlights from this year – from exciting company updates to thought leadership articles.
We are proud to be a finalist for the award of ‘Scale-up de l’Année – Scale-up of the…
We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…
Drug development has changed significantly throughout the past 2 decades – including great leaps forward in areas from…
New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…